Inventor · disambiguated record
Ryan P. Larson
Also filed as: LARSON RYAN · LARSON RYAN P
5 granted patents·10 pending applications·3 citations·filing 2018–2025
66Inventor score
Top patents by PatentIndex Score
15 records- 0175US12161670B2Phenotypic markers for cell therapy and related methodsJUNO THERAPEUTICS INC·Filed 2018·Granted Dec 10, 2024·1 cites·20 claims
- 0275US2024151713A1Articles of manufacture and methods related to toxicity associated with cell therapyJUNO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0372US12258580B2Process for generating therapeutic compositions of engineered cellsJUNO THERAPEUTICS INC·Filed 2018·Granted Mar 25, 2025·2 cites·41 claims
- 0469US2025059253A1Phenotypic markers for cell therapy and related methodsJUNO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0565US2024158837A1Epigenetic analysis of cell therapy and related methodsJUNO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0662US11740231B2Articles of manufacture and methods related to toxicity associated with cell therapyJUNO THERAPEUTICS INC·Filed 2018·Granted Aug 29, 2023·0 cites·33 claims
- 0761US2025367290A1Engineered stem cells and uses thereofUMOJA BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 0859US2025051801A1Viral particle with surface stimulating moleculesUMOJA BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0954US11821027B2Epigenetic analysis of cell therapy and related methodsJUNO THERAPEUTICS INC·Filed 2018·Granted Nov 21, 2023·0 cites·29 claims
- 1053US2025171739A1Process for generating therapeutic compositions of engineered cellsJUNO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1152US2025041415A1Cytotoxic innate lymphoid cell and uses thereofUMOJA BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 1251US2023181641A1Process for producing donor-batched cells expressing a recombinant receptorJUNO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1348US2021393691A1Process for producing genetically engineered t cellsJUNO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1445US2022008465A1Methods of dosing engineered t cells for the treatment of b cell malignanciesJUNO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1539US12163952B2Determining toxicity risk in CAR T-cell therapyJUNO THERAPEUTICS INC·Filed 2018·Granted Dec 10, 2024·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when Ryan P. Larson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →